As we continue to further our understanding of the novel coronavirus, its epidemiological characteristics, associated risk factors and possible avenues for treatment, take a look at the top 10 most-read articles so far on COVID-19.
A global research consortium has provided new evidence suggesting that neutrophils may be responsible for severe symptoms linked to COVID-19.
Take a look behind the scenes of a recent Future Virology editorial entitled, ‘An insight into dengue virus proteins as potential drug/vaccine targets’, as we ask author Muhammad Faheem about recent advances in understanding dengue proteins and where the next 5–10 years could take us.
Emerging evidence has suggested that B cells and humoral immunity could modulate the immune response to intracellular pathogens. We speak to Babak Javid about his research on this topic and the importance of learning about immune factors in order to develop vaccination strategies and to understand latent TB.
A team of researchers have uncovered a protein, AGO4, which may have the potential to be used as a therapeutic target to universally increase protection against viral pathogens.
In October 2019 researchers from Brazil identified a new parasite, which presented with similar symptoms to visceral leishmaniasis. To discover more about this novel parasite and other parasitic diseases in Brazil, we interviewed Sandra Maruyama from the Federal University of São Carlos (UFSCar; São Paulo, Brazil) about her research and the future of this field.
Take a look behind the scenes of a recent Future Microbiology article, entitled ‘New insights of CRISPR technology in pathogenic fungi’, as we ask author Elvira Román (Complutense University of Madrid, Spain) about the advances CRISPR technology has already brought to this field and the potential it could hold in the future.
The WHO has declared that the COVID-19 outbreak can be characterized as a pandemic as new cases are reported globally, including a huge spike in cases in South Korea, Italy and Iran and over 100 other countries reporting cases.
In this interview, we speak to Jenn Edwards from the Abigail Wexner Research Institute (OH, USA) about her research using the primary human epithelial cell models to examine Neisseria gonorrhoeae infections, the potential for vaccination against gonorrhea and a possible host-targeted therapy for this infection.
Researchers have uncovered a novel mechanism utilized by group A streptococcus that allows it to evade detection by the immune system in infected mice, providing insight for the development of effective countermeasures against this pathogen.
